Actively Recruiting
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Led by Kong Fanming · Updated on 2025-09-08
84
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observation and exploration of the improvement in cough symptoms in postoperative lung cancer patients with Transcutaneous Acupoint Electrical Stimulation (TAES), the change in Cough Symptom Score (CSS) compared to baseline, the change in Visual Analog Scale (VAS) score for cough symptoms compared to baseline, the change in total score of Leicester Cough Questionnaire-Mandarin Chinese version (LCQ-MC) compared to baseline, and overall evaluation of treatment effectiveness by patients. A total of 84 postoperative lung cancer patients with cough were strictly selected according to the inclusion/exclusion criteria and treated and followed up according to the research plan requirements. Clinical observation forms were completed and clinical data were recorded in the database. Statistical analysis was performed on relevant clinical observation indicators to report research results and write related papers.
CONDITIONS
Official Title
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years old
- Surgery performed under general anesthesia for radical resection of lung cancer or lung cancer resection combined with lymph node dissection
- Pathological confirmation of primary lung cancer after surgery
- Persistent dry cough lasting 2 weeks or more after lung surgery
- Consciousness, ability to express opinions clearly, and voluntary signing of informed consent
You will not qualify if you...
- Diagnosis of acute respiratory system diseases within 1 month
- Diagnosis of pneumonia based on chest X-ray
- History of asthma or tuberculosis
- Uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infection, coagulation disorders, or other severe systemic diseases
- Use of steroid drugs within the past 3 months
- Use of angiotensin-converting enzyme inhibitors (ACEIs) within the past 6 months
- Surgical incisions, skin allergies, wounds, or infections in the treatment area
- Inability to tolerate transcutaneous acupoint electrical stimulation or withdrawal during the procedure
- Contraindications to transcutaneous electrical stimulation or implanted electrophysiological devices
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China, 300193
Actively Recruiting
Research Team
F
Fanming Kong, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here